Deyaa Adib

Company: Triumvira Immunologics
Job title: Chief Medical Officer
Seminars:
Exploring Cell Therapies in HER2 Solid Tumors 9:00 am
• Discussing target engagement and response biomarkers • Targeting tumors, targeted therapies & more • Exploring T cell Antigen Coupler (TAC) technologyRead more
day: Day Two